Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
NCT ID: NCT06560255
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
2000 participants
INTERVENTIONAL
2024-12-20
2033-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood
NCT00798226
Fish Oil Supplementation in Lactation
NCT00266305
Milk Types and Fish Oil in 9- to 12-Month-Old Infants
NCT00379171
Essential Fatty Acids During Complementary Feeding
NCT00631046
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
NCT00226187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
n-3 fatty acid of 2.4 g per day
Oral intake of 4 capsules daily from week 22-26 of gestation until 1 week after delivery
n-3 fatty acid
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Rape seed oil
Oral intake of 4 capsules daily from week 22-26 of gestation until 1 week after delivery
Rape seed oil
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
n-3 fatty acid
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Rape seed oil
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No planned use of fish oil supplementations
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Professor Klaus Bønnelykke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Klaus Bønnelykke
Professor PhD, Head of COPSAC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo Chawes, PhD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Studies on Asthma in Childhood
Klaus Bønnelykke, PhD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen Studies on Asthma in Childhood
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital of Copenhagen
Gentofte Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Brustad N, Vahman N, Ralfkiaer U, Mikkelsen M, Brandt S, Kyvsgaard JN, Vinding R, Stokholm J, Chawes B, Bonnelykke K. Fish oil and vitamin D in pregnancy for the prevention of early childhood asthma: study protocol for two double-blinded, randomised controlled trials. BMJ Open. 2024 Dec 31;14(12):e092902. doi: 10.1136/bmjopen-2024-092902.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-23055833-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.